JP2020524164A5 - - Google Patents

Download PDF

Info

Publication number
JP2020524164A5
JP2020524164A5 JP2019570550A JP2019570550A JP2020524164A5 JP 2020524164 A5 JP2020524164 A5 JP 2020524164A5 JP 2019570550 A JP2019570550 A JP 2019570550A JP 2019570550 A JP2019570550 A JP 2019570550A JP 2020524164 A5 JP2020524164 A5 JP 2020524164A5
Authority
JP
Japan
Prior art keywords
cells
medicament according
subject
merkel cell
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019570550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020524164A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/038308 external-priority patent/WO2018236887A1/en
Publication of JP2020524164A publication Critical patent/JP2020524164A/ja
Publication of JP2020524164A5 publication Critical patent/JP2020524164A5/ja
Pending legal-status Critical Current

Links

JP2019570550A 2017-06-20 2018-06-19 Nk−92細胞を用いてメルケル細胞癌(mcc)を治療するための方法 Pending JP2020524164A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762522335P 2017-06-20 2017-06-20
US62/522,335 2017-06-20
PCT/US2018/038308 WO2018236887A1 (en) 2017-06-20 2018-06-19 Methods for treating merkel cell carcinoma (mcc) using nk-92 cells

Publications (2)

Publication Number Publication Date
JP2020524164A JP2020524164A (ja) 2020-08-13
JP2020524164A5 true JP2020524164A5 (enExample) 2021-07-26

Family

ID=62875317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019570550A Pending JP2020524164A (ja) 2017-06-20 2018-06-19 Nk−92細胞を用いてメルケル細胞癌(mcc)を治療するための方法

Country Status (9)

Country Link
US (1) US20200171087A1 (enExample)
EP (1) EP3641790A1 (enExample)
JP (1) JP2020524164A (enExample)
KR (1) KR20200017494A (enExample)
CN (1) CN110753551A (enExample)
AU (1) AU2018288712A1 (enExample)
CA (1) CA3066463A1 (enExample)
IL (1) IL270838A (enExample)
WO (1) WO2018236887A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105848662A (zh) 2013-11-01 2016-08-10 南克维斯特公司 杀肿瘤和抗微生物组合物和方法
WO2022250312A1 (ko) * 2021-05-27 2022-12-01 (주)에스엠티바이오 신경내분비종양의 치료용 자연살해세포

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2263205T3 (es) 1997-04-30 2006-12-01 Hans Klingemann Estirpes celulares citoliticas naturales y metodos de uso.

Similar Documents

Publication Publication Date Title
JP2013533858A5 (enExample)
EA201650134A1 (ru) Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором
SA522432668B1 (ar) طرق لعلاج سرطان الرئة للخلايا الصغيرة بصيغ من لوربينيكتيدين
RU2013123646A (ru) Комбинированная композиция
JP2018526460A5 (enExample)
JP2016526531A5 (enExample)
RU2015152860A (ru) Режим введения и составы для аденовирусов типа в
JP2016515586A5 (enExample)
JP2015532293A5 (ja) 糖尿病患者における心不全の治療用組成物
MX2024006799A (es) Metodos para el tratamiento de cáncer con prame positivo.
JP2020524164A5 (enExample)
JP2017537927A5 (enExample)
JP2020536923A5 (enExample)
WO2017142871A8 (en) Methods comprising fixed intermittent dosing of cediranib
JP2020524167A5 (enExample)
JP2018516920A5 (enExample)
JP2018522881A5 (enExample)
MX2021008986A (es) Metodos de tratamiento de un paciente con enfermedad de parkinson.
RU2297219C2 (ru) Способ лечения больных колоректальным раком с метастазами в печень
RU2424013C1 (ru) Способ лечения рака прямой кишки
JPWO2021119316A5 (enExample)
MX2023000384A (es) Metodo para tratar un cancer positivo para gd2.
RU2007120091A (ru) Способ лечения больных местно-распространенным немелкоклеточным раком легкого
RU2023102211A (ru) Схемы дозирования иммуноконъюгата anti-folr1
MINGRINO et al. EFFECTS OF METHYL-PREDNISOLONE CLINICAL AND RADIOLOGICAL EVALUATION